Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides-Reference-Cited by-同舟云学术

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides

Published:2011-10 Issue:7369 Volume:478 Page:404-407
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Rayner Katey J.,Esau Christine C.,Hussain Farah N.,McDaniel Allison L.,Marshall Stephanie M.,van Gils Janine M.,Ray Tathagat D.,Sheedy Frederick J.,Goedeke Leigh,Liu Xueqing,Khatsenko Oleg G.,Kaimal Vivek,Lees Cynthia J.,Fernandez-Hernando Carlos,Fisher Edward A.,Temel Ryan E.,Moore Kathryn J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature10486.pdf

Reference20 articles.

1. deGoma, E. M. & Rader, D. J. Novel HDL-directed pharmacotherapeutic strategies. Nature Rev. Cardiol. 8, 266–277 (2011)

2. Moore, K. J., Rayner, K. J., Suarez, Y. & Fernandez-Hernando, C. MicroRNAs and cholesterol metabolism. Trends Endocrinol. Metab. 21, 699–706 (2010)

3. Marquart, T. J., Allen, R. M., Ory, D. S. & Baldan, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl Acad. Sci. USA 107, 12228–12232 (2010)

4. Najafi-Shoushtari, S. H. et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566–1569 (2010)

5. Rayner, K. J. et al. miR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570–1573 (2010)

Cited by 640 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs in Anticancer Drugs Hepatotoxicity: From Pathogenic Mechanism and Early Diagnosis to Therapeutic Targeting by Natural Products;Current Pharmaceutical Biotechnology;2024-10

2. Metabolic dysfunction−associated liver disease and diabetes: Matrix remodeling, fibrosis, and therapeutic implications;Annals of the New York Academy of Sciences;2024-07-12

3. Specific circulating miRNAs are associated with plasma lipids in a healthy American cohort;Physiological Genomics;2024-07-01

4. Resveratrol suppresses hepatic fatty acid synthesis and increases fatty acid β-oxidation via the microRNA-33/SIRT6 signaling pathway;Experimental and Therapeutic Medicine;2024-06-19

5. Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches;Current Atherosclerosis Reports;2024-06-13